CYTOSORBENTS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CYTOSORBENTS CORPORATION (CTSO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 799.85 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 2.00K shares, a 98.10% decline year-over-year.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 797.85K shares, a 1919.87% increase year-over-year.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 25.80K shares, a 91.27% decline year-over-year.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 642.50K shares, a 107.93% increase year-over-year.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 812.80K shares, a 79.59% decline from fiscal 2024.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.98M shares, a 53.08% increase from fiscal 2023.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.60M shares, a 36.33% decline from fiscal 2022.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 4.09M shares, a 99.13% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 799.85K shares 10-Q · filed 2026-08-06 | 825.65K shares derived: sum of 3 quarters · filed 2026-08-06 | 1.47M shares derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | 797.85K shares 10-Q · filed 2026-05-13 | 823.65K shares derived: sum of 2 quarters · filed 2026-05-13 | 1.47M shares derived: sum of 3 quarters · filed 2026-05-13 | 1.57M shares derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2025-12-31 | 25.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 668.30K shares derived: sum of 2 quarters · filed 2026-03-30 | 773.30K shares derived: sum of 3 quarters · filed 2026-03-30 | 812.80K shares 10-K · filed 2026-03-30 | |||
| 2025-09-30 | 642.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 747.50K shares derived: sum of 2 quarters · filed 2025-11-13 | 787.00K shares 10-Q · filed 2025-11-13 | 1.08M shares derived: sum of 4 quarters · filed 2026-03-30 | |||
| 2025-06-30 | 105.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 144.50K shares 10-Q · filed 2025-08-07 | 439.98K shares derived: sum of 3 quarters · filed 2026-03-30 | 748.98K shares derived: sum of 4 quarters · filed 2026-03-30 | |||
| 2025-03-31 | 39.50K shares 10-Q · filed 2025-05-14 | 334.98K shares derived: sum of 2 quarters · filed 2026-03-30 | 643.98K shares derived: sum of 3 quarters · filed 2026-03-30 | 3.62M shares derived: sum of 4 quarters · filed 2026-03-30 | |||
| 2024-12-31 | 295.48K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 604.48K shares derived: sum of 2 quarters · filed 2026-03-30 | 3.58M shares derived: sum of 3 quarters · filed 2026-03-30 | 3.98M shares 10-K · filed 2026-03-30 | |||
| 2024-09-30 | 309.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 3.28M shares derived: sum of 2 quarters · filed 2024-11-07 | 3.69M shares 10-Q · filed 2024-11-07 | 3.71M shares derived: sum of 4 quarters · filed 2025-03-31 | |||
| 2024-06-30 | 2.97M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 3.38M shares 10-Q · filed 2024-08-13 | 3.40M shares derived: sum of 3 quarters · filed 2025-03-31 | 5.83M shares derived: sum of 4 quarters · filed 2025-03-31 | |||
| 2024-03-31 | 406.48K shares 10-Q · filed 2024-05-09 | 424.48K shares derived: sum of 2 quarters · filed 2025-03-31 | 2.85M shares derived: sum of 3 quarters · filed 2025-03-31 | 2.91M shares derived: sum of 4 quarters · filed 2025-03-31 | |||
| 2023-12-31 | 18.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 2.45M shares derived: sum of 2 quarters · filed 2025-03-31 | 2.50M shares derived: sum of 3 quarters · filed 2025-03-31 | 2.60M shares 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 2.43M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 2.48M shares derived: sum of 2 quarters · filed 2023-11-09 | 2.58M shares 10-Q · filed 2023-11-09 | 4.00M shares derived: sum of 4 quarters · filed 2024-03-15 | |||
| 2023-06-30 | 54.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | 154.00K shares 10-Q · filed 2023-08-01 | 1.57M shares derived: sum of 3 quarters · filed 2024-03-15 | 4.12M shares derived: sum of 4 quarters · filed 2024-03-15 | |||
| 2023-03-31 | 100.00K shares 10-Q · filed 2023-05-02 | 1.51M shares derived: sum of 2 quarters · filed 2024-03-15 | 4.07M shares derived: sum of 3 quarters · filed 2024-03-15 | 4.13M shares derived: sum of 4 quarters · filed 2024-03-15 | |||
| 2022-12-31 | 1.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 3.97M shares derived: sum of 2 quarters · filed 2024-03-15 | 4.03M shares derived: sum of 3 quarters · filed 2024-03-15 | 4.09M shares 10-K · filed 2024-03-15 | 2.72M shares 10-K · filed 2023-03-09 | ||
| 2022-09-30 | 2.55M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 2.62M shares derived: sum of 2 quarters · filed 2022-11-03 | 2.67M shares 10-Q · filed 2022-11-03 | 2.74M shares derived: sum of 4 quarters · filed 2024-03-15 | |||
| 2022-06-30 | 63.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 119.75K shares 10-Q · filed 2022-08-02 | 184.25K shares derived: sum of 3 quarters · filed 2024-03-15 | 339.25K shares derived: sum of 4 quarters · filed 2024-03-15 | |||
| 2022-03-31 | 56.50K shares 10-Q · filed 2022-05-03 | 121.00K shares derived: sum of 2 quarters · filed 2024-03-15 | 276.00K shares derived: sum of 3 quarters · filed 2024-03-15 | 2.04M shares derived: sum of 4 quarters · filed 2024-03-15 | |||
| 2021-12-31 | 64.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 219.50K shares derived: sum of 2 quarters · filed 2024-03-15 | 1.99M shares derived: sum of 3 quarters · filed 2024-03-15 | 2.05M shares 10-K · filed 2024-03-15 | |||
| 2021-09-30 | 155.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 1.92M shares derived: sum of 2 quarters · filed 2021-11-04 | 1.99M shares 10-Q · filed 2021-11-04 | 1.97M shares derived: sum of 4 quarters · filed 2023-03-09 | |||
| 2021-06-30 | 1.77M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 1.83M shares 10-Q · filed 2021-08-03 | 1.82M shares derived: sum of 3 quarters · filed 2023-03-09 | 1.86M shares derived: sum of 4 quarters · filed 2023-03-09 | |||
| 2021-03-31 | 65.88K shares 10-Q · filed 2021-05-04 | 51.16K shares derived: sum of 2 quarters · filed 2023-03-09 | 91.16K shares derived: sum of 3 quarters · filed 2023-03-09 | 198.66K shares derived: sum of 4 quarters · filed 2023-03-09 | |||
| 2020-12-31 | -14.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 25.28K shares derived: sum of 2 quarters · filed 2023-03-09 | 132.78K shares derived: sum of 3 quarters · filed 2023-03-09 | 1.58M shares 10-K · filed 2023-03-09 | |||
| 2020-09-30 | 40.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 147.50K shares derived: sum of 2 quarters · filed 2020-11-04 | 1.59M shares 10-Q · filed 2020-11-04 | 1.62M shares derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-06-30 | 107.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 1.55M shares 10-Q · filed 2020-08-04 | 1.58M shares derived: sum of 3 quarters · filed 2022-03-10 | 2.98M shares derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-03-31 | 1.45M shares 10-Q · filed 2020-05-05 | 1.47M shares derived: sum of 2 quarters · filed 2022-03-10 | 2.87M shares derived: sum of 3 quarters · filed 2022-03-10 | 2.94M shares derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-02-28 | 1.11M shares 10-K · filed 2023-03-09 | 1.04M shares 10-Q · filed 2020-08-04 | |||||
| 2019-12-31 | 28.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 1.42M shares derived: sum of 2 quarters · filed 2022-03-10 | 1.50M shares derived: sum of 3 quarters · filed 2022-03-10 | 1.56M shares 10-K · filed 2022-03-10 | |||
| 2019-09-30 | 1.40M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 1.47M shares derived: sum of 2 quarters · filed 2019-11-05 | 1.53M shares 10-Q · filed 2019-11-05 | 1.58M shares derived: sum of 4 quarters · filed 2021-03-09 | |||
| 2019-06-30 | 73.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 133.80K shares 10-Q · filed 2019-08-06 | 187.30K shares derived: sum of 3 quarters · filed 2021-03-09 | 263.30K shares derived: sum of 4 quarters · filed 2021-03-09 | |||
| 2019-03-31 | 60.80K shares 10-Q · filed 2019-05-07 | 114.30K shares derived: sum of 2 quarters · filed 2021-03-09 | 190.30K shares derived: sum of 3 quarters · filed 2021-03-09 | 878.35K shares derived: sum of 4 quarters · filed 2021-03-09 | |||
| 2018-12-31 | 53.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | 129.50K shares derived: sum of 2 quarters · filed 2021-03-09 | 817.55K shares derived: sum of 3 quarters · filed 2021-03-09 | 1.48M shares 10-K · filed 2021-03-09 | |||
| 2018-09-30 | 76.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 764.05K shares derived: sum of 2 quarters · filed 2018-11-06 | 1.43M shares 10-Q · filed 2018-11-06 | 1.45M shares derived: sum of 4 quarters · filed 2020-03-05 | |||
| 2018-06-30 | 688.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 1.35M shares 10-Q · filed 2018-08-02 | 1.38M shares derived: sum of 3 quarters · filed 2020-03-05 | 1.38M shares derived: sum of 4 quarters · filed 2020-03-05 | |||
| 2018-03-31 | 664.13K shares 10-Q · filed 2018-05-08 | 688.13K shares derived: sum of 2 quarters · filed 2020-03-05 | 689.13K shares derived: sum of 3 quarters · filed 2020-03-05 | 843.13K shares derived: sum of 4 quarters · filed 2020-03-05 | |||
| 2017-12-31 | 24.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | 25.00K shares derived: sum of 2 quarters · filed 2020-03-05 | 179.00K shares derived: sum of 3 quarters · filed 2020-03-05 | 1.20M shares 10-K · filed 2020-03-05 | |||
| 2017-09-30 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 155.00K shares derived: sum of 2 quarters · filed 2017-11-09 | 1.18M shares 10-Q · filed 2017-11-09 | 1.19M shares derived: sum of 4 quarters · filed 2019-03-07 | |||
| 2017-06-30 | 154.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 1.18M shares 10-Q · filed 2017-08-07 | 1.19M shares derived: sum of 3 quarters · filed 2019-03-07 | 1.19M shares derived: sum of 4 quarters · filed 2019-03-07 | |||
| 2017-03-31 | 1.03M shares 10-Q · filed 2017-05-08 | 1.04M shares derived: sum of 2 quarters · filed 2019-03-07 | 1.04M shares derived: sum of 3 quarters · filed 2019-03-07 | 2.05M shares derived: sum of 4 quarters · filed 2019-03-07 | |||
| 2016-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 13.00K shares derived: sum of 2 quarters · filed 2019-03-07 | 1.03M shares derived: sum of 3 quarters · filed 2019-03-07 | 1.04M shares 10-K · filed 2019-03-07 | |||
| 2016-09-30 | 3.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | 1.02M shares derived: sum of 2 quarters · filed 2016-11-07 | 1.03M shares 10-Q · filed 2016-11-07 | 1.06M shares derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2016-06-30 | 1.02M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 1.03M shares 10-Q · filed 2016-08-09 | 1.05M shares derived: sum of 3 quarters · filed 2018-03-08 | 1.09M shares derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2016-03-31 | 16.12K shares 10-Q · filed 2016-05-09 | 37.12K shares derived: sum of 2 quarters · filed 2018-03-08 | 71.12K shares derived: sum of 3 quarters · filed 2018-03-08 | 686.12K shares derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2015-12-31 | 21.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 55.00K shares derived: sum of 2 quarters · filed 2018-03-08 | 670.00K shares derived: sum of 3 quarters · filed 2018-03-08 | 681.00K shares 10-K · filed 2018-03-08 | |||
| 2015-09-30 | 34.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | 649.00K shares derived: sum of 2 quarters · filed 2015-11-13 | 660.00K shares 10-Q · filed 2015-11-13 | ||||
| 2015-06-30 | 615.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 626.00K shares 10-Q · filed 2015-08-13 | |||||
| 2015-03-31 | 11.00K shares 10-Q · filed 2015-05-11 | ||||||
| 2014-12-31 | 732.80K shares 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |